University College London Hospitals NHS Foundation Trust (UCLH), situated in the heart of London, is one of the largest NHS Trusts in the United Kingdom, providing first-class acute and specialist services in seven hospitals. The Trust balances the provision of highly rated, specialist services with acute services to the local populations of Camden, Islington, Westminster, Barnet, Enfield and Haringey. The Trust has a turnover of £738 million and contracts with over 70 commissioning bodies. UCLH hospitals see over 740,000 out-patients and admit over 115,000 patients each year.
UCLH specialises in women’s health and the treatment of cancer, cardiac, infection, neurological, gastrointestinal and oral disease.
In 2010 the Trust was chosen to be one of eight hyper-acute stroke units (HASUs) in London. HASUs treat patients in the first, vital, 72 hours after a stroke. The UCLH Hyper Acute Stroke Unit (HASU) opened at full capacity in July 2010 and expects an annual caseload of 1,800 patients. The in-hospital mortality for patients treated through HASU has been exceptionally low at 6%, compared to the national average of 27%.
The Trust is committed to pioneering clinical research. In December 2006, in partnership with University College London (UCL), UCLH became one of the country’s five comprehensive biomedical research centres. In addition to this, the Trust is a founder member of the academic health science centre, UCL Partners, which brings together five of Britain’s world renowned medical research centres and hospitals. UCLP continues to lead to ground-breaking advances in research for the benefit of patients by sharing best practice across the partnership and promoting links to other centres of excellence in clinical research.
In April 2012, UCLH opened the UCH Macmillan Cancer Centre – the most advanced facility of its kind in the UK.
At any one time around 1,300 leading edge research projects are on-going across the Trust’s hospital sites, including over 200 clinical trials of medicinal products. The Trust works with over 60 medical research charities and industry partners.
- In 2011 the Trust was named London NHS hospital Trust of the year by the Dr Foster Hospital Guide. This was the second time in just three years that UCLH has been named a Dr Foster Trust of the Year and the third time in a decade
- UCLH operates the best performing A&E in London against the four hour waiting time target
- UCLH’s Hospital Standardised Mortality Rate is 67, one of the lowest rates nationally
- In 2011 UCLH received the best CQC inpatient survey results for a non-single specialty hospital in London. For ‘overall views and experience’ UCLH was in the top 20% of Trusts nationally for the second year running
- The latest NHS staff survey shows that the people who work at the Trust would recommend UCLH as a place to receive treatment
- 97% of UCLH patients would recommend the Trust to family and friends
Chief Executive: Professor Marcel Levi
Professor Marcel Levi joined UCLH as chief executive in January 2017. He has had a distinguished career as a clinician, academic, educator and clinical leader. Prior to joining UCLH he was chairman of the executive board of the Academic Medical Center, University of Amsterdam, for six years and before that, he was chairman of its Department of Medicine and Division of Medical Specialisms for ten years. Marcel is a practising consultant physician at UCLH, specialising in haemostasis, thrombosis and vascular medicine. He was named the best specialist in internal medicine in the Netherlands for three consecutive years. Marcel obtained his PhD in 1991 and was appointed a Fellow by the Royal Netherlands Academy of Science. He continues to lead an active research programme and has had more than 500 research papers published in international journals. Marcel was named Dutchman of the Year 2016 by a leading magazine in the Netherlands in recognition of his professional success